Nafie Esraa H, Abou-Gamra Maha M, Mossalem Hanan S, Sarhan Rania M, Hammam Olfat A, Nasr Sami M, Anwar Mona M
Departments of Medical Parasitology Department, Faculty of Medicine, Ain Shams University, Ramsis St., Abbassia, Cairo, 11566 Egypt.
Departments of Medical Malacology, Theodor Bilharz Research Institute, El-Nile St., Warrak El-Hader, P.O. BOX 30, Imbaba, Giza, Egypt.
J Parasit Dis. 2024 Sep;48(3):551-569. doi: 10.1007/s12639-024-01692-0. Epub 2024 Jun 26.
Schistosomiasis is a neglected tropical disease with considerable morbidity. The lone effective drug, praziquantel (PZQ), is showing emergence of drug resistance hence, searching for new supportive treatment is crucial. This study aimed to evaluate the efficacy of mucus and nucleoproteins (NPs) extracted from () snails on miracidia, cercariae and () adults in vitro and assess their experimental in vivo effect through parasitological, histopathological, and biochemical parameters. The in vivo study included 90 male Swiss albino mice. Mice were grouped into 9 groups; G1-G5 were infected and treated with; GI: PZQ, GII: mucus, GIII: combined PZQ and mucus, GIV: NPs, GV: combined PZQ and NPs. Control groups; C: Non infected non treated (negative control), C: Infected non treated (positive control), C: Non infected mucus treated and C: Non infected NPs treated. The in vitro study proved that the mucus had a better lethal effect on cercariae than miracidia, while NPs had better lethal effect on miracidia. The mucus lethal effect on adults surpassed the NPs as 100% and 60%, respectively. The in vivo study proved that the combined NPs or mucus with PZQ added to the effect of individual PZQ resulting in 100% total worm burden (TWB) reduction. As regard oxidative stress markers, the lowest level of nitric oxide (NO) was shown with combined PZQ and NPs. While, the highest glutathione (GSH) level was produced by individual PZQ. The study concluded that mucus and NPs of had cercaricidal, miracidicidal and anti-schistosomal effect in vitro and that their combination could be considered a contribution to PZQ potentiality in vivo.
血吸虫病是一种被忽视的热带疾病,发病率相当高。唯一有效的药物吡喹酮(PZQ)正显示出耐药性的出现,因此,寻找新的辅助治疗方法至关重要。本研究旨在评估从()蜗牛中提取的黏液和核蛋白(NPs)在体外对毛蚴、尾蚴和()成虫的疗效,并通过寄生虫学、组织病理学和生化参数评估其体内实验效果。体内研究包括90只雄性瑞士白化小鼠。小鼠被分为9组;G1 - G5组感染并接受以下治疗:GI组:吡喹酮;GII组:黏液;GIII组:吡喹酮与黏液联合使用;GIV组:核蛋白;GV组:吡喹酮与核蛋白联合使用。对照组:C组:未感染未治疗(阴性对照),C组:感染未治疗(阳性对照),C组:未感染黏液治疗组,C组:未感染核蛋白治疗组。体外研究证明,黏液对尾蚴的致死作用比对毛蚴更好,而核蛋白对毛蚴的致死作用更好。黏液对成虫的致死作用分别以100%和60%超过核蛋白。体内研究证明,核蛋白或黏液与吡喹酮联合使用增强了吡喹酮单独使用的效果,使总虫负荷(TWB)降低了100%。关于氧化应激标志物,吡喹酮与核蛋白联合使用时一氧化氮(NO)水平最低。而谷胱甘肽(GSH)水平最高是由吡喹酮单独产生的。该研究得出结论,()的黏液和核蛋白在体外具有杀尾蚴、杀毛蚴和抗血吸虫作用,并且它们的联合使用可被认为有助于增强吡喹酮在体内的潜力。